Sign in

CIK 0001395064

  • Large accelerated filer

TAKEDA PHARMACEUTICAL CO LTD

Sign in to watch
Ticker
TKPHF
Exchange
NYSE, OTC
Industry
Pharmaceutical Preparations
Entity type
Other
Phone
+81 332782111
Business address
1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, Japan, 103-8668

Securities

  • TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) NYSE
  • TKPHF Common stock OTC
  1. 4 Grant or award Pres., Global Supply & Quality acquired 30,094 shares (grant or award)
  2. 4 Grant or award Chief Transformation Officer acquired 45,140 shares (grant or award)
  3. 4 Grant or award President, OBU acquired 43,886 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 73,234 shares (grant or award)
  5. 4 Grant or award President, R&D acquired 125,390 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Grant or award President and CEO acquired 244,270 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 7,800 shares (grant or award)
  12. 4 Grant or award President, R&D acquired 212,470 shares (grant or award)
  13. 4 Grant or award Chief Data & Tech. Officer acquired 34,994 shares (grant or award)
  14. 4 Grant or award President, OBU acquired 64,988 shares (grant or award)
  15. 4 Grant or award Chief Transformation Officer acquired 59,990 shares (grant or award)
  16. 4 Grant or award CEO - Elect acquired 105,416 shares (grant or award)
  17. 4 Grant or award President, IBU acquired 72,124 shares (grant or award)
  18. 4 Grant or award Head, Strat. & Port. Dev. acquired 27,740 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 3 of 7 · 137 filings